These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 1643802
21. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function. Verdonk CA, Rizza RA, Nelson RL, Go VL, Gerich JE, Service FJ. J Clin Invest; 1980 May; 65(5):1119-25. PubMed ID: 6988457 [Abstract] [Full Text] [Related]
22. Stimulation of insulin secretion by intravenous bolus injection and continuous infusion of gastric inhibitory polypeptide in patients with type 2 diabetes and healthy control subjects. Meier JJ, Gallwitz B, Kask B, Deacon CF, Holst JJ, Schmidt WE, Nauck MA. Diabetes; 2004 Dec; 53 Suppl 3():S220-4. PubMed ID: 15561915 [Abstract] [Full Text] [Related]
23. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Vollmer K, Holst JJ, Baller B, Ellrichmann M, Nauck MA, Schmidt WE, Meier JJ. Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091 [Abstract] [Full Text] [Related]
27. The effect of insulin deprivation on fasting levels of 5000 dalton gastric inhibitory polypeptide in type 1 (insulin-dependent) diabetics. Krarup T, Madsbad S, Regeur L, Alberti KG, Faber OK, Kurtz A. Diabete Metab; 1985 Dec; 11(6):364-7. PubMed ID: 3910488 [Abstract] [Full Text] [Related]
28. Gastric inhibitory polypeptide in obesity and diabetes mellitus. Service FJ, Rizza RA, Westland RE, Hall LD, Gerich JE, Go VL. J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812 [Abstract] [Full Text] [Related]
36. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response. Tura A, Bagger JI, Ferrannini E, Holst JJ, Knop FK, Vilsbøll T, Mari A. Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1123-1129. PubMed ID: 29162361 [Abstract] [Full Text] [Related]
37. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8. Nauck M, Schmidt WE, Ebert R, Strietzel J, Cantor P, Hoffmann G, Creutzfeldt W. J Clin Endocrinol Metab; 1989 Sep; 69(3):654-62. PubMed ID: 2668324 [Abstract] [Full Text] [Related]
39. Hypersecretion of gastric inhibitory polypeptide following oral glucose in diabetes mellitus. Ross SA, Brown JC, Dupré J. Diabetes; 1977 Jun; 26(6):525-9. PubMed ID: 324834 [Abstract] [Full Text] [Related]
40. Impairment of the insulinotropic effect of gastric inhibitory polypeptide (GIP) in obese and diabetic rats is related to the down-regulation of its pancreatic receptors. Younan SM, Rashed LA. Gen Physiol Biophys; 2007 Sep; 26(3):181-93. PubMed ID: 18063845 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]